000 01295nam a2200361 i 4500
001 on1049175074
003 OCoLC
005 20190208144235.0
006 m o d f
007 cr mn|||||||||
008 180822s2016 dcua o f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
_dMvI
042 _apcc
043 _an-us---
074 _a0967 (online)
086 0 _aJ 24.2:C 19
099 _aJ 24.2:C 19
245 0 0 _aCarfentanil :
_ba dangerous new factor in the U.S. opioid crisis.
264 1 _a[Washington, D.C.] :
_bDrug Enforcement Administration,
_c[2016?]
300 _a1 online resource (1 unnumbered page) :
_bcolor illustration.
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
490 0 _aOffice safety alert
588 _aDescription based on online resource; title from PDF caption (U.S. Department of Justice website, viewed Aug. 22, 2018).
500 _aCRDP Program record.
650 0 _aSynthetic drugs
_zUnited States.
650 0 _aFentanyl
_zUnited States.
650 0 _aOpioid abuse
_zUnited States.
650 0 _aDrug abuse
_zUnited States.
710 1 _aUnited States.
_bDrug Enforcement Administration,
_eissuing body.
856 4 0 _uhttps://purl.fdlp.gov/GPO/gpo107901
999 _c278722
_d278722